Changes in the state of a cell as it responds to signals delivered by soluble mediators as well as by engagement of ligands displayed on cell surfaces or on extracellular matrices are the basis of differentiation, development, and the activation of effector functions. The molecular mechanisms by which ligands of cell surface receptors elicit such changes occupy not only a large proportion of the time and interest of cell and molecular biologists, but also account for an extensive fraction of the prokaryotic and eukaryotic genomes and proteomes. Complex systems that lend themselves to a deep analysis of such cell-signaling events include the network by which the immune system communicates within and among its major components: T cells, B cells, NK cells, and APCs. The study of T cells and the means of their activation have been augmented by our understanding of the primary sensor of...
Skip Nav Destination
Article navigation
21 April 2003
Commentary|
April 21 2003
CD28, Costimulator or Agonist Receptor?
David H. Margulies
David H. Margulies
Molecular Biology Section, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), Bethesda, MD 20892
Search for other works by this author on:
David H. Margulies
Molecular Biology Section, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), Bethesda, MD 20892
Address correspondence to David H. Margulies, Molecular Biology Section, Laboratory of Immunology, NIAID, NIH, DHHS, Building 10, Room 11N311, Bethesda, MD 20892. Phone: 301-496-6429; Fax: 301-496-0222; E-mail: [email protected]
Received:
February 24 2003
Accepted:
February 27 2003
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2003
J Exp Med (2003) 197 (8): 949–953.
Article history
Received:
February 24 2003
Accepted:
February 27 2003
Citation
David H. Margulies; CD28, Costimulator or Agonist Receptor? . J Exp Med 21 April 2003; 197 (8): 949–953. doi: https://doi.org/10.1084/jem.20030303
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement